Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gunther

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Leukemia & Lymphoma|August 3, 2019
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function<sup>.</sup>Jillian R Gunther, Chanhyun Park, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Advances in Radiation Oncology|November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the LungSusan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
British Journal of Haematology|December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphomaJay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
American Journal of Hematology|February 21, 2019
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphomaPaolo Strati, Seung Tae Lee, Purnima Teegavarupu, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Leukemia & Lymphoma|August 3, 2019
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function<sup>.</sup>Jillian R Gunther, Chanhyun Park, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Advances in Radiation Oncology|November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the LungSusan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
British Journal of Haematology|December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphomaJay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
American Journal of Hematology|February 21, 2019
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphomaPaolo Strati, Seung Tae Lee, Purnima Teegavarupu, et al.
Pageof 26